介入性肿瘤学市场规模、份额和成长分析（按产品类型、手术类型、癌症类型、最终用户和地区划分）－2026-2033年产业预测

全球介入性肿瘤学市场规模预计在 2024 年达到 23.1 亿美元，从 2025 年的 24.7 亿美元成长到 2033 年的 41.8 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.8%。

介入性肿瘤学是癌症治疗领域一个快速发展的分支，它结合了微创手术和先进的影像技术，包括CT、超音波、MRI和X光。这些手术旨在精准靶向并清除癌细胞，同时最大限度地减少侵入性手术的需求。利用血管内导管、切片穿刺针和消融电极等专用器械，即使肿瘤位于体内远处，也能有效标标靶化。介入性肿瘤学与传统的肿瘤治疗方法（包括放射治疗、手术和内科肿瘤学）相结合，提供以缓解症状和改善预后为重点的治疗，从而提升患者的整体体验。这种方法适用于多种癌症类型，包括肝癌、肾癌、肺癌和乳癌，凸显了其在现代癌症治疗管理中的核心地位。

全球介入性肿瘤市场按产品、癌症类型、手术方式、最终用户和地区进行细分。依产品划分，可分为栓塞装置、消融装置和辅助装置。依癌症类型划分，可分为肝癌、肾癌、乳癌、肺癌、骨癌、摄护腺癌和其他癌症。依手术方式划分，可分为经导管动脉放射乳化/选择性体内放射疗法（TARE/SIRT）、经导管动脉化疗栓塞术（TACE）、热消融术和经导管动脉栓塞/盲栓塞术（TAE）。依最终用户划分，可分为医院、门诊手术中心以及科研和学术机构。按地区划分，可分为北美、欧洲、亚太、中东和非洲以及拉丁美洲。

全球介入性肿瘤学市场驱动因素

全球癌症发生率的不断攀升是介入肿瘤学市场的主要驱动力。随着世界人口老化和生活方式相关风​​险因素导致癌症发生率上升，对有效治疗方案的需求持续成长。这种日益增长的需求促使医疗专业人员采用先进的介入技术来改善患者预后并提高存活率。对创新治疗方法的关注体现了应对癌症挑战的决心，最终推动了介入肿瘤学领域的发展，并促进了患者照护和復原的进步。

全球介入肿瘤学市场面临的限制因素

全球介入肿瘤学市场成长的主要限制因素是医疗专业人员对介入性肿瘤学技术的认知和训练不足。许多医疗专业人员不熟悉最新的创新技术和流程，导致这些技术未能充分利用。此外，专业培训的需求也会阻碍新技术在各种医疗机构中的快速应用，从而为将这些先进技术有效整合到日常患者照护中带来挑战。这种知识和训练的匮乏最终会影响全球介入肿瘤学市场的整体发展和扩张。

全球介入性肿瘤学市场趋势

全球介入肿瘤学市场正经历着向微创技术的重大转变，这主要源于患者和医疗服务提供者对能够最大限度缩短恢復时间和减少併发症的治疗方法日益增长的偏好。这一趋势得益于技术的进步，促进了创新工具和调查方法的开发，从而提高了治疗的精准度和疗效。人们对这些方法的益处认识不断提高，促使人们更加关注标靶治疗不仅能改善患者预后，还能优化医疗资源配置。介入性肿瘤学的这一发展标誌着变革时期，其特征是患者照护和满意度的显着提升。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管环境

全球介入性肿瘤市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 消融装置
  • 射频消融装置
  • 微波消融装置
  • 冷冻消融装置
  • 不可逆电穿孔装置
  • 高强度聚焦超音波（HIFU）系统
• 栓塞装置
  • 放射性栓塞装置（Y-90微球）
  • 经动脉化疗栓塞术（TACE）药物
  • 药物释放型球（DEBs）
  • 非药物释放型珠
• 支援的设备
  • 微导管
  • 导管导引线
  • 针头（用于切片检查和消融）
  • 导入器和鞘套
  • 造影
• 其他的
  • 机器人辅助系统
  • 规划和导航软体平台

全球介入性肿瘤市场规模（依手术类型和复合年增长率划分）（2026-2033 年）

• 热凝固疗法
• 非热消融
• 栓塞术
• 椎体成形术和骨水泥注射
• 切片检查和肿瘤标记程序

全球介入性肿瘤学市场规模：癌症类型及复合年增长率（2026-2033）

• 肝癌
• 肺癌
• 肾癌
• 骨转移
• 乳癌
• 摄护腺癌
• 胰臟癌
• 大肠直肠癌
• 其他的

全球介入性肿瘤市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心（ASC）
• 癌症研究中心
• 介入放射科诊所

全球介入性肿瘤市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boston Scientific Corporation-USA
• Medtronic plc-Ireland
• Siemens Healthineers-Germany
• Terumo Corporation-Japan
• Becton, Dickinson and Company（BD）-USA
• Merit Medical Systems-USA
• AngioDynamics, Inc.-USA
• ALPINION MEDICAL SYSTEMS-South Korea
• ATRICURE, INC.-USA
• EndoShape, Inc.-USA
• ABK Biomedical Inc.-Canada
• Cook Medical Inc.-USA
• Sirtex Medical Limited-Australia
• BTG International Ltd.-UK
• Hologic, Inc.-USA
• Canon Medical Systems Corporation-Japan
• GE Healthcare-USA
• Philips Healthcare-Netherlands

结论与建议

Global Interventional Oncology Market size was valued at USD 2.31 Billion in 2024 and is poised to grow from USD 2.47 Billion in 2025 to USD 4.18 Billion by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

Interventional oncology represents a rapidly growing segment of cancer care that utilizes minimally invasive techniques combined with advanced imaging technologies such as CT, ultrasound, MRI, and X-rays. These procedures are designed to precisely target and eliminate cancer cells, minimizing the need for invasive surgeries. Utilizing specialized instruments like intravascular catheters, biopsy needles, and ablation electrodes ensures effective targeting of tumors, even those in remote areas of the body. The integration of interventional oncology with traditional oncology approaches-such as radiation therapy, surgery, and medical oncology-enhances the overall patient experience by providing focused treatments that relieve symptoms and improve outcomes. This approach is applicable to various cancers, including liver, kidney, lung, and breast cancers, emphasizing its pivotal role in contemporary cancer management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Interventional Oncology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Interventional Oncology Market Segments Analysis

Global Interventional Oncology Market is segmented on the basis of product, cancer type, procedure, end user, and region. By product, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. By Cancer Type, the market is segmented into Liver Cancer, Kidney Cancer, Breast Cancer, Lung Cancer, Bone Cancer, Prostate Cancer, and Other Cancers. By procedure, the market is segmented into Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy (TARE/SIRT), Transcatheter Arterial Chemoembolization (TACE), Thermal Tumor Ablation, and Transcatheter Arterial Embolization/Bland Embolization (TAE). By end-user, the market is segmented into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Interventional Oncology Market

The rising incidence of cancer worldwide significantly fuels the interventional oncology market. As the global population ages and lifestyle-related risk factors contribute to higher cancer rates, the need for effective treatment solutions continues to surge. This escalating demand encourages healthcare professionals to embrace advanced interventional techniques that improve patient outcomes and boost survival rates. The focus on innovative treatment methods reflects a commitment to addressing the challenges posed by cancer, ultimately driving the growth of the interventional oncology sector and fostering advancements in patient care and recovery.

Restraints in the Global Interventional Oncology Market

A significant constraint on the growth of the Global Interventional Oncology market is the limited awareness and training among healthcare professionals regarding interventional oncology techniques. Many practitioners lack familiarity with the latest innovations and procedures, which contributes to their underutilization. Furthermore, the necessity for specialized training can impede the swift adoption of new technologies across various healthcare environments, posing a challenge to effectively integrating these advanced practices into regular patient care. This lack of knowledge and training ultimately affects the overall development and expansion of interventional oncology within the global market.

Market Trends of the Global Interventional Oncology Market

The Global Interventional Oncology market is witnessing a pronounced shift towards minimally invasive techniques, reflecting a growing preference among patients and healthcare providers for treatments that minimize recovery times and complications. This trend is propelled by advancements in technology, fostering the development of innovative tools and methodologies that enhance precision and treatment efficacy. As awareness of the benefits of these approaches spreads, there is an increasing emphasis on targeted therapies that not only improve patient outcomes but also optimize healthcare resources. This evolution in interventional oncology signifies a transformative period characterized by enhanced patient care and satisfaction.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Interventional Oncology Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Ablation Devices
  • Radiofrequency (RF) Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Irreversible Electroporation Devices
  • High-Intensity Focused Ultrasound (HIFU) Systems
• Embolization Devices
  • Radioembolization Devices (Y-90 Microspheres)
  • Transarterial Chemoembolization (TACE) Agents
  • Drug-Eluting Beads (DEBs)
  • Non-drug-eluting Beads
• Support Devices
  • Microcatheters
  • Guidewires
  • Needles (biopsy, ablation)
  • Introducers and Sheaths
  • Imaging Contrast Agents
• Others
  • Robotic Assistance Systems
  • Software Platforms for Planning and Navigation

Global Interventional Oncology Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Thermal Ablation
• Non-thermal Ablation
• Embolization Procedures
• Vertebroplasty & Cementoplasty
• Biopsy and Tumor Marking Procedures

Global Interventional Oncology Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Liver Cancer
• Lung Cancer
• Kidney Cancer
• Bone Metastases
• Breast Cancer
• Prostate Cancer
• Pancreatic Cancer
• Colorectal Cancer
• Others

Global Interventional Oncology Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Cancer Research Centers
• Interventional Radiology Clinics

Global Interventional Oncology Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Cancer Type, End User)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Cancer Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Cancer Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Cancer Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Cancer Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boston Scientific Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALPINION MEDICAL SYSTEMS - South Korea
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATRICURE, INC. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EndoShape, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABK Biomedical Inc. - Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sirtex Medical Limited - Australia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BTG International Ltd. - UK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare - Netherlands
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations